Bacterial diarrhea is the second most common cause of morbidity and mortality in developing and underdeveloped countries and among the causative agents,
Escherichia coli (E. coli) plays a dominant role in community acquired enteritis (
1,
2). The
E. coli is a type of bacteria that lives in the human intestine, as normal flora; however, five distinct pathotypes have been characterized, including enteroaggregative
E. coli (EAEC), enteroinvasive
E. coli (EIEC), enterohemorrhagic
E. coli, enteropathogenic
E. coli (EPEC), and enterotoxigenic
E. coli (ETEC) that cause diseases (
3). The EAEC is an important etiologic agent of diarrhea among children and is increasingly recognized as a global emerging pathogen, with potential threat to public health (
4-
6). It was first described in 1985, recognized by its distinctive adherence to HEp-2 cells in an aggregative, stacked brick-like pattern, and also its tendency to attach to abiotic surfaces, when grown in tissue culture plates (
7,
8). This bacterium produces a watery diarrhea and can cause symptoms, such as abdominal pain and fever, in children, as well as adults. Most prominently, besides causing acute diarrhea, it can also persist in the human intestine subclinically, inducing chronic inflammation in the absence of dysentery (
9). In addition, the pathogenic potential of EAEC has been demonstrated by the emergence of recent food borne outbreaks, most notably in Germany in 2011 (
10). The frequency of diarrhea in developed and developing countries differs and poor sanitation and crowded living conditions increase the propensity for EAEC to spread in developing countries. The EAEC is also linked to diarrhea in adults, including HIV‐positive patients and travelers visiting less developed regions of the world. Recently, it was found that EAEC isolates are associated with extraintestinal infections, such urinary tract infections (UTIs) and hemolytic uremic syndrome (HUS) (
11,
12).
At the molecular level, a diagnostic probe was initially constructed for polymerase chain reaction (PCR) amplification of a 630-bp fragment of a plasmid encoded autotransporter adherence pCVD432 (aatA) gene, in harboring strains (
13). Principally, among adherence genes, fimbriae I and II (AAF/I and AAF/II), which are required for attachment to surfaces and form biofilm, as well as the AAF/III that help EAEC strains bind loosely to epithelial cells, were identified. The AAF was assigned into several distinct alleles, including four major pilin variants (aggA, aafA, agg3A and agg4A) (
14).
Similarly, plasmid encoded serine protease autotransporters of Enterobacteriaceae (SPATE) toxins detected in several EAEC strains that cause increased mucus release, exfoliation of cells and development of crypt abscesses (
15). This family comprises two classes; class-I consists of the cytotoxic genes, which include pet and sat (
16) and class-II include the genes involved in colonization (pic) and Shigella extracellular protease (sepA), which appears to be involved in tissue invasion (
17). In addition, several strains of EAEC produce enterotoxins, such as the enteroaggregative heat stable toxin-1 (EAST1) and the Shigella enterotoxin-1 (ShET1) (
18).
Little information is available on the prevalence of EAEC infections in Iran. A PCR method, based on identifying the presence of the virulence genes pCVD432, aggR, aggA, aafA, aap, and astA was used among EAEC isolated from fecal samples, in Tehran (
19). In another study from Iran, out of 715 stool samples collected from patients showing diarrhea in Shiraz, 101 diarrhoeagenic
E. coli were identified, five of which confirmed as EAEC (
20). Similarly, Bouzari et al. (
21) isolated 98
E. coli strains that displayed the aggregative adherence pattern on HeLa cells and hybridized with the pCVD432 probe.